After initial assessment, 115 patients (67 males/48 females, mean age SD 65.2 10.4 years, range 3586) were selected to receive oral semaglutide and 177 patients (105 males/72 females, mean age SD 62.4 10.0 years, range 2787) were prescribed once-weekly subcutaneous semaglutide
Acknowledgements The author thanks Morten Donsmark and Tine Bkdal (both Novo Nordisk A/S, Sborg, Denmark), and Kazushiro Fujiwara, and Eirik Quamme Bergan (both Novo Nordisk Pharma Ltd, Tokyo, Japan) for reviewing the manuscript, and to Andy Bond of Spirit Medical Communications Group Ltd for medical writing and editorial assistance (funded by Novo Nordisk A/S, Sborg, Denmark)
Prioritize Sleep Poor sleep boosts hunger hormones and reduces energy
MeAgain's GLP-1 app can help you manage semaglutide, allowing you to stay on track with your weight loss journey
Managing Side Effects Some patients may experience side effects such as nausea or gastrointestinal discomfort, especially when first starting semaglutide GLP-1